HighVista Strategies’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
112,805
+17,646
| +19% | +$264K | 0.62% | 57 |
|
|
2025
Q1 | $1.54M | Hold |
95,159
| – | – | 0.59% | 66 |
|
|
2024
Q4 | $2.22M | Sell |
95,159
-10,192
| -10% | -$237K | 0.82% | 36 |
|
|
2024
Q3 | $3.1M | Sell |
105,351
-8,199
| -7% | -$241K | 1.07% | 27 |
|
|
2024
Q2 | $2.67M | Sell |
113,550
-40,831
| -26% | -$960K | 0.98% | 29 |
|
|
2024
Q1 | $5.86M | Sell |
154,381
-423,235
| -73% | -$16.1M | 2.09% | 3 |
|
|
2023
Q4 | $12.4M | Buy |
+577,616
| New | +$12.4M | 4.51% | 2 |
|
|
2021
Q4 | – | Sell |
-525
| Closed | -$105K | – | 114 |
|
|
2021
Q3 | $105K | Buy |
+525
| New | +$105K | 0.07% | 93 |
|